Yes, you're possibly quite right. But I expect that if they had received all results, including re-assays, we'd have the scoping study on our screens or in our hands.
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-21
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.471M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $5.355K | 1.245M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 25142014 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7003101 | 8 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| ADG (ASX) Chart |